1. Home
  2. BDSX vs NNBR Comparison

BDSX vs NNBR Comparison

Compare BDSX & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • NNBR
  • Stock Information
  • Founded
  • BDSX 2005
  • NNBR 1980
  • Country
  • BDSX United States
  • NNBR United States
  • Employees
  • BDSX N/A
  • NNBR N/A
  • Industry
  • BDSX Precision Instruments
  • NNBR Industrial Machinery/Components
  • Sector
  • BDSX Health Care
  • NNBR Industrials
  • Exchange
  • BDSX Nasdaq
  • NNBR Nasdaq
  • Market Cap
  • BDSX 194.9M
  • NNBR 197.7M
  • IPO Year
  • BDSX 2020
  • NNBR 1994
  • Fundamental
  • Price
  • BDSX $1.51
  • NNBR $3.68
  • Analyst Decision
  • BDSX Strong Buy
  • NNBR
  • Analyst Count
  • BDSX 4
  • NNBR 0
  • Target Price
  • BDSX $3.08
  • NNBR N/A
  • AVG Volume (30 Days)
  • BDSX 332.5K
  • NNBR 121.3K
  • Earning Date
  • BDSX 11-01-2024
  • NNBR 10-30-2024
  • Dividend Yield
  • BDSX N/A
  • NNBR N/A
  • EPS Growth
  • BDSX N/A
  • NNBR N/A
  • EPS
  • BDSX N/A
  • NNBR N/A
  • Revenue
  • BDSX $65,562,000.00
  • NNBR $470,310,000.00
  • Revenue This Year
  • BDSX $46.97
  • NNBR N/A
  • Revenue Next Year
  • BDSX $30.43
  • NNBR $0.71
  • P/E Ratio
  • BDSX N/A
  • NNBR N/A
  • Revenue Growth
  • BDSX 48.92
  • NNBR N/A
  • 52 Week Low
  • BDSX $1.11
  • NNBR $2.84
  • 52 Week High
  • BDSX $2.21
  • NNBR $5.40
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 48.94
  • NNBR 36.06
  • Support Level
  • BDSX $1.24
  • NNBR $3.88
  • Resistance Level
  • BDSX $1.43
  • NNBR $3.98
  • Average True Range (ATR)
  • BDSX 0.10
  • NNBR 0.17
  • MACD
  • BDSX 0.01
  • NNBR -0.05
  • Stochastic Oscillator
  • BDSX 64.44
  • NNBR 1.30

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.

Share on Social Networks: